Evidence map›Paper›PMID 34097050›Full record

ArticleJAMA network open2021

Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children.

Lyudmyla Kompaniyets, Nickolas T Agathis, Jennifer M Nelson, Leigh Ellyn Preston, Jean Y Ko, Brook Belay, Audrey F Pennington, Melissa L Danielson, Carla L DeSisto, Jennifer R Chevinsky and 8 more

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 224 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
224citing papers in PubMed, 6 pooled it
105.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

224 citing papers in PubMed, 6 syntheses or guidelines pooled it, 411 citations in OpenAlex.

  1. Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.Journal of the Pediatric Infectious Diseases Society · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Review
  20. Observational

164 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Lyudmyla KompaniyetsCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Nickolas T AgathisCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Jennifer M NelsonCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Leigh Ellyn PrestonCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Jean Y KoCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Brook BelayCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Audrey F PenningtonCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Melissa L DanielsonCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Carla L DeSistoCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Jennifer R ChevinskyCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Lyna Z SchieberCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Hussain YusufCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
James BaggsCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
William R Mac KenzieCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Karen K WongCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Tegan K BoehmerCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Adi V GundlapalliCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Alyson B GoodmanCOVID-19 Response, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Centers for Disease Control and Prevention · USUnited States Public Health Service Commissioned Officers Association · USEpidemic Intelligence Service · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Information on underlying conditions and severe COVID-19 illness among children is limited. Objective: To examine the risk of severe COVID-19 illness among children associated with underlying medical conditions and medical complexity. Design, Setting, and Participants: This cross-sectional study included patients aged 18 years and younger with International Statistical Classification of Diseases, Tenth Revision, Clinical Modification code U07.1 (COVID-19) or B97.29 (other coronavirus) during an emergency department or inpatient encounter from March 2020 through January 2021. Data were collected from the Premier Healthcare Database Special COVID-19 Release, which included data from more than 800 US hospitals. Multivariable generalized linear models, controlling for patient and hospital characteristics, were used to estimate adjusted risk of severe COVID-19 illness associated with underlying medical conditions and medical complexity. Exposures: Underlying medical conditions and medical complexity (ie, presence of complex or noncomplex chronic disease). Main Outcomes and Measures: Hospitalization and severe illness when hospitalized (ie, combined outcome of intensive care unit admission, invasive mechanical ventilation, or death). Results: Among 43 465 patients with COVID-19 aged 18 years or younger, the median (interquartile range) age was 12 (4-16) years, 22 943 (52.8%) were female patients, and 12 491 (28.7%) had underlying medical conditions. The most common diagnosed conditions were asthma (4416 [10.2%]), neurodevelopmental disorders (1690 [3.9%]), anxiety and fear-related disorders (1374 [3.2%]), depressive disorders (1209 [2.8%]), and obesity (1071 [2.5%]). The strongest risk factors for hospitalization were type 1 diabetes (adjusted risk ratio [aRR], 4.60; 95% CI, 3.91-5.42) and obesity (aRR, 3.07; 95% CI, 2.66-3.54), and the strongest risk factors for severe COVID-19 illness were type 1 diabetes (aRR, 2.38; 95% CI, 2.06-2.76) and cardiac and circulatory congenital anomalies (aRR, 1.72; 95% CI, 1.48-1.99). Prematurity was a risk factor for severe COVID-19 illness among children younger than 2 years (aRR, 1.83; 95% CI, 1.47-2.29). Chronic and complex chronic disease were risk factors for hospitalization, with aRRs of 2.91 (95% CI, 2.63-3.23) and 7.86 (95% CI, 6.91-8.95), respectively, as well as for severe COVID-19 illness, with aRRs of 1.95 (95% CI, 1.69-2.26) and 2.86 (95% CI, 2.47-3.32), respectively. Conclusions and Relevance: This cross-sectional study found a higher risk of severe COVID-19 illness among children with medical complexity and certain underlying conditions, such as type 1 diabetes, cardiac and circulatory congenital anomalies, and obesity. Health care practitioners could consider the potential need for close observation and cautious clinical management of children with these conditions and COVID-19.

Indexed as

Adolescent HealthChild HealthSeverity of Illness IndexAdolescentCardiovascular AbnormalitiesChildChild, PreschoolChronic DiseaseComorbidityCOVID-19Cross-Sectional StudiesDiabetes Mellitus, Type 1Emergency Service, HospitalFemaleHospitalizationHumans

Identifiers

PMID34097050
PMCPMC8185607
OpenAlexW3173119869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.